[go: up one dir, main page]

MXPA01008605A - Proteina de enlace del antigeno goodpasture. - Google Patents

Proteina de enlace del antigeno goodpasture.

Info

Publication number
MXPA01008605A
MXPA01008605A MXPA01008605A MXPA01008605A MXPA01008605A MX PA01008605 A MXPA01008605 A MX PA01008605A MX PA01008605 A MXPA01008605 A MX PA01008605A MX PA01008605 A MXPA01008605 A MX PA01008605A MX PA01008605 A MXPA01008605 A MX PA01008605A
Authority
MX
Mexico
Prior art keywords
antigen binding
binding protein
gpbp
goodpasture antigen
goodpasture
Prior art date
Application number
MXPA01008605A
Other languages
English (en)
Inventor
Juan Saus
Original Assignee
Juan Saus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22397008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA01008605(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Juan Saus filed Critical Juan Saus
Publication of MXPA01008605A publication Critical patent/MXPA01008605A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Rehabilitation Therapy (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion proporciona secuencias de acidos nucleicos aislados y vectores de expresion que codifican a la proteina de enlace del antigeno Goodpasture (GPBP), GPBP sustancialmente purificados, anticuerpos en contra del GPBP y metodos para la deteccion del GPBP.
MXPA01008605A 1999-02-24 2000-02-24 Proteina de enlace del antigeno goodpasture. MXPA01008605A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12148399P 1999-02-24 1999-02-24
PCT/IB2000/000324 WO2000050607A2 (en) 1999-02-24 2000-02-24 Goodpasture antigen binding protein

Publications (1)

Publication Number Publication Date
MXPA01008605A true MXPA01008605A (es) 2003-06-24

Family

ID=22397008

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01008605A MXPA01008605A (es) 1999-02-24 2000-02-24 Proteina de enlace del antigeno goodpasture.

Country Status (10)

Country Link
US (5) US6579969B1 (es)
EP (1) EP1144650B1 (es)
JP (1) JP3761784B2 (es)
AT (1) ATE316577T1 (es)
AU (1) AU760197B2 (es)
CA (1) CA2361987C (es)
DE (1) DE60025704T2 (es)
ES (1) ES2254151T3 (es)
MX (1) MXPA01008605A (es)
WO (1) WO2000050607A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060459B2 (en) 2000-12-08 2006-06-13 Juan Saus TNF-inducible promoters and methods for using
US6881547B1 (en) * 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
WO2004070025A2 (en) * 2003-02-05 2004-08-19 Juan Saus Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
JP2005035926A (ja) * 2003-07-14 2005-02-10 Japan Science & Technology Agency セラミド輸送を促進する薬剤、該薬剤を製造する塩基配列、セラミド遊離を促進する活性の測定方法、及びセラミドの膜間移動を促進する活性の測定方法
SI2126093T1 (sl) * 2007-03-02 2013-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Izboljšanje priprave proteinov
WO2009078240A1 (ja) 2007-12-17 2009-06-25 Kureha Corporation 深絞り用熱収縮性積層フィルム、包装体及びチーズの包装方法
US20100017232A1 (en) * 2008-07-18 2010-01-21 StevenDale Software, LLC Information Transmittal And Notification System
EP2318039B1 (en) * 2008-07-22 2015-04-08 Fibrostatin, Sociedad Limitada Goodpasture antigen binding protein and its detection
SG175332A1 (en) 2009-05-05 2011-11-28 Boehringer Ingelheim Int Cho / cert cell lines
WO2011054530A1 (en) 2009-11-05 2011-05-12 Fibrostatin, S.L. Gpbp inhibition using q2 peptidomimetics
US20120213800A1 (en) 2011-02-21 2012-08-23 Fibrostatin S.L. Methods for treating and diagnosing disease
EP2866835A1 (en) 2012-07-02 2015-05-06 Fibrostatin, S.L. Gpbp-1 inhibition and its therapeutic use
WO2016107906A1 (en) 2014-12-31 2016-07-07 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424408A (en) * 1990-11-30 1995-06-13 Yale University α-3 chain type IV collagen polynucleotides
US6007980A (en) 1990-11-30 1999-12-28 Yale University Alpha-3 chain type IV collagen polypeptides
WO1993016179A1 (en) * 1992-02-17 1993-08-19 Howard Florey Institute Of Experimental Physiology And Medicine MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription
JP2001507563A (ja) * 1995-11-23 2001-06-12 キャンサー リサーチ キャンペーン テクノロジー リミテッド Ｂｒｃａ２癌感受性遺伝子の同定及び配列決定に関する材料及び方法並びにそれらの使用

Also Published As

Publication number Publication date
ES2254151T3 (es) 2006-06-16
DE60025704T2 (de) 2006-09-07
JP3761784B2 (ja) 2006-03-29
US7189517B2 (en) 2007-03-13
WO2000050607A2 (en) 2000-08-31
WO2000050607A3 (en) 2000-11-30
AU3314000A (en) 2000-09-14
DE60025704D1 (de) 2006-04-13
EP1144650B1 (en) 2006-01-25
AU760197B2 (en) 2003-05-08
US7186527B2 (en) 2007-03-06
US20030049791A1 (en) 2003-03-13
US6579969B1 (en) 2003-06-17
US20070178540A1 (en) 2007-08-02
JP2003525023A (ja) 2003-08-26
CA2361987A1 (en) 2000-08-31
CA2361987C (en) 2007-07-03
US20100247553A1 (en) 2010-09-30
EP1144650A2 (en) 2001-10-17
US7629132B2 (en) 2009-12-08
ATE316577T1 (de) 2006-02-15
US20030054488A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
HK1046287A1 (en) Ibd-associated microbial antigens and methods of using same
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
WO1999020756A3 (en) Human toll homologues
AU2154801A (en) Method for linking molecular substances
WO1999067382A3 (en) Angiopoietin-like growth factor sequences
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
HK1049185A1 (zh) 可改螢光蛋白
IL128212A0 (en) Detection of small molecules by use of a piezo electric sensor
EP1258018A4 (en) REAGENTS, METHODS AND KITS FOR PROTEIN DETECTION i BACILLUS THURINGIENSIS / i
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
WO2002042458A3 (en) G protein coupled receptors
IL152062A0 (en) G protein coupled receptor
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof
WO2001085786A3 (en) Human histamine h4 receptor
WO2000065055A8 (en) Human transporter proteins
WO2001059114A3 (en) Tumor suppressor gene, p47ing3

Legal Events

Date Code Title Description
FG Grant or registration